Skip to main content
Signal8
Bensler Graydon profile photo

Graydon Bensler

CIK: 0002003447

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

PMGC Holdings Inc. logo
ELAB

PMGC Holdings Inc.

DirectorOfficer
AQUABOUNTY TECHNOLOGIES INC logo
aqb

AQUABOUNTY TECHNOLOGIES INC

Director
Qualigen Therapeutics, Inc. logo
QLGN

Qualigen Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • PMGC Holdings Inc. logo
    ELAB

    PMGC Holdings Inc.

    Jun 1, 2026
    Award(A)

    Options

    Indirect
    450.3K shares-
  • PMGC Holdings Inc. logo
    ELAB

    PMGC Holdings Inc.

    Mar 26, 2025
    Award(A)
    Indirect
    3M shares-

1-2 of 2

About Bensler Graydon

Bensler Graydon (SEC CIK 0002003447) files insider reports with the SEC as Chief Executive Officer of PMGC Holdings Inc. (ELAB), Director of AQUABOUNTY TECHNOLOGIES INC (AQB) and Director of Qualigen Therapeutics, Inc. (QLGN).

Signal8 holds 5 ownership filings by Bensler Graydon (3 Form 3, 2 Form 4), filed between Nov 15, 2024 and Jun 3, 2026. Those filings report 2 transactions, from Mar 26, 2025 to Jun 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Bensler Graydon's filings is in NEWPORT BEACH, CA.

Recent filings by Bensler Graydon

  • Jun 1, 2026: Grant or award of ELAB derivative securities (Form 4, code A).
  • Mar 26, 2025: Grant or award of ELAB shares (Form 4, code A).

Other insiders filing for PMGC Holdings Inc. (ELAB)

How to read Form 4 transaction codes